Long-Term Survival of Patients After Ipilimumab and Hypofractionated Brain Radiotherapy for Brain Metastases of Malignant Melanoma: Sequence Matters

Strahlentherapie und Onkologie - Germany
doi 10.1007/s00066-018-1356-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Whole Brain Radiotherapy (WBRT) After Local Treatment of Brain Metastases in Melanoma Patients: Statistical Analysis Plan

Trials
MedicinePharmacology
2019English

Cone-Beam Computed Tomography in Hypofractionated Stereotactic Radiotherapy for Brain Metastases

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Determinants of Survival in Patients With Brain Metastases From Cutaneous Melanoma

British Journal of Cancer
Cancer ResearchOncology
2010English

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Hypofractionated Radiation Therapy for Large Brain Metastases

Frontiers in Oncology
Cancer ResearchOncology
2018English

OA13.07 Survival Outcomes After Whole Brain Radiotherapy for Brain Metastases in Elderly Patients With Newly Diagnosed Metastatic Small Cell Carcinoma.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Stereotactic Radiosurgery With or Without Whole Brain Radiotherapy for Patients With One to Three Melanoma Brain Metastases

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Toward Shared Decision: Validated Clinical Nomogram for Personalized Long-Term Survival Prediction After Radiosurgery for Brain Metastases

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Improved Time to Disease Progression in the Brain in Patients With Melanoma Brain Metastases Treated With Concurrent Delivery of Radiosurgery and Ipilimumab

OncoImmunology
OncologyAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy